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Abstract
Introduction. Strain and strain rate (SR) are techniques, which provide local information on myocardial deformation. 
The aim of the study was to assess the usefulness of strain and SR measurement in cardiac resynchronization therapy 
(CRT) response in chronic heart failure (CHF) patients.
Materials and methods. The study included 35 CHF patients with QRS complex duration ≥ 120ms with LBBB morphol-
ogy. Biochemical and clinical parameters were assessed before and after six months of CRT. TTE classical and tissue 
Doppler echocardiography parameters (longitudinal peak systolic strain — LPS and SR for basal segment of intraven-
tricular septum and lateral wall) were evaluated. 
Results. Twenty-two patients (62.8%) benefited from CRT (the responders) and revealed improvement in septal and 
lateral LPS in the 6-month observation [-7.1 (-5.2– -11.1) vs -12.1 (-8.7– -14)%, p = 0.002; - 10.4 (-6.1– -17.6) vs - 13.8 
(-8.9 – -17.8)%, p = 0.03; respectively]. Six months after CRT, the responders were characterised by higher increase 
in septal LPS comparing to the nonresponders (-4.6 ± 6.1 vs -2.4 ± 3.9%, p = 0.045). Septal LPS changes correlated 
positively with baseline cardiopulmonary exercise testing (CPET) parameters: peak oxygen uptake (r = 0.6, p = 0.004), 
peak carbon dioxide excretion (r = 0.62, p = 0.002) and negatively with VE/VCO2 slope (r = -0.5, p = 0.037). 
Conclusions. LV regional LPS appears to be a good parameter reflecting the improvement of clinical status in patients 
treated with CRT. The responders had better improvement of septal LPS, therefore positive response to this therapy may 
be related to the improvement of septal contractility.
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treatment methods, that may reverse the course of the 
disease. CRT effectiveness is based on biventricular pa-
cing, that can improve systolic function of the heart by cor-
recting the electromechanical dyssynchrony. That results 
in an improvement of patients functional capacity, as well 
as reduction of rehospitalisations and mortality [7]. One 
of the clinical assessment methods of CHF patients is car-
diopulmonary exercise testing (CPET). Among the variety of 
CPET parameters, peak oxygen uptake (VO2 peak) remains 
one of the strongest prognostic values [8]. The weak point 
of CPET is limited availability and dependence of patient’s 
motor skills, therefore echocardiography still plays an 
important role in the evaluation of those patients and the 
novel echocardiographic methods for CRT-response eva-
luation are sought after. Among a variety of parameters 
reflecting response to the therapy, LVEF remains one of 
the most commonly used, as well as one of the strongest 
predictors of long term prognosis. However, LVEF or left 
ventricle end-systolic (LVEsV) and end–diastolic volumes 
(LVEdV) do not provide local information on myocardial 
deformation. Despite prognostic properties of the regional 
contractility assessment, that have been confirmed by 
Donal et al. [9], there is no clear evidence on the use of 
this method in the evaluation of patients treated with CRT.
The aim of the study was: 1) to compare classical 
and new echocardiographic parameters — peak systolic 
longitudinal strain (LPS) and SR — in the assessment of LV 
function before and six months after CRT implantation in 
CHF patients, 2) to assess the value of LPS measurement 
usefulness in clinical and biochemical response to CRT, 
and 3) to determine whether they differ between CRT re-
sponders and nonresponders and may be a potential tool 
for postoperative optimisation of CRT.
Materials and methods
The study group
The study included 35 consecutive patients with stable, 
optimally pharmacologically treated CHF with LVEF lower 
than 35% assessed in echocardiography, who were hospi-
talised at the Cardiology Department from 2011 to 2014. 
The aetiology of heart failure included dilated (13 cases) or 
ischaemic cardiomyopathy (22 cases). All of these patients 
had sinus rhythm in ECG, QRS complex duration >120 ms 
and left bundle branch block (LBBB) and further underwent 
the procedure of CRT device implantation with the best 
possible location of left-ventricular electrode. The locali-
sation of left-ventricular electrode is presented in Table 1.
All the patients underwent the same diagnostic as-
sessment: medical interview with the assessment of NYHA 
functional class, physical examination, transthoracic echo-
cardiography (TTE), CPET, six-minute walk test (6MWT) and 
venous blood tests. Those measurements were obtained 
before implantation of CRT device and after six months 
Introduction
A reliable assessment of myocardial function is crucial for 
the diagnosis, treatment, and prognosis of cardiovascular 
diseases. Echocardiography plays an indispensable role in 
cardiac imaging due to its real-time acquisition and wide 
availability. Left ventricular ejection fraction (LVEF) is one 
of the most widely used indicators of left ventricular (LV) 
heart function. This volume-based assessment of heart 
function suffers, however, from a lack of reproducibility 
and standardisation. Furthermore, newer, more sensitive 
techniques have shown that LV function can be reduced de-
spite a normal LVEF. These two techniques have dominated 
the research area of echocardiography: 1. Doppler-based 
tissue velocity measurements, frequently referred to as 
Doppler Tissue Imaging (DTI), and 2. speckle tracking on 
the basis of displacement measurements (Two-Dimensional 
(2D) Speckle-Tracking Echocardiography (STE)). Both types 
of these currently available techniques allow quantitative 
assessment of myocardial function. Strain and strain rate 
(SR) are basic parameters of myocardial function used to 
assess local wall dynamics and to provide local information 
on myocardial deformation and may be assessed with the 
use of echocardiography and, significantly less available, 
cardiac magnetic resonance imaging [1]. The important 
advantage of strain and SR is that they reflect regional 
function independently of translational motion [2]. Little is 
known about usefulness of those parameters in the evalua-
tion of cardiac resynchronization therapy (CRT) response in 
patients with chronic heart failure (CHF). The advantage of 
these techniques over conventional methods of LV systolic 
function estimation is the opportunity of early detection 
of myocardial dysfunction undetectable in the standard 
protocol echocardiography. The assessment of mechanical 
dyssynchrony in patients treated with or planned for CRT 
is a recent concept that arose from the clinical need for 
better patient selection and means of therapy optimisation. 
Although the concept is mostly accepted among experts 
despite recent challenges, clinical value of the approach 
remains to be better defined [2]. Despite promising data, 
quantitative assessment of the magnitude of regional LV 
deformation cannot be recommended at this stage because 
of lack of reference values, suboptimal reproducibility, and 
considerable inter-vendor measurement variability [3]. On 
the other hand, observational studies have shown, that 
longitudinal strain analysis reflects the segmental hete-
rogeneity of myocardial function [4] and that the increase 
in global longitudinal strain correlates with the degree of 
LV remodelling [5]. Lim et al. [6] published very promising 
results derived from algorithms based on longitudinal 
strain peaks and the relation between peaks and end-
-systolic values.
In recent years, a significant improvement of CHF pa-
tients therapy has been observed and CRT is one of the 
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In our study, we used DTI technique to evaluate my-
ocardial deformation and those data were expressed as 
strain and strain rate. We assessed peak longitudinal 
strain during LV systole, which is the most commonly used 
deformation parameter. DTI acquisition was performed 
according to the American Society of Echocardiography 
and the European Association of Echocardiography gu-
idelines. Apical four-chamber views in 2D greyscale and 
tissue colour Doppler imaging (at a frame rate about 
140 frames/sec) were acquired in all the patients. Only 
echocardiograms with an optimal frame rate over 100 per 
second were analysed.
All images was transferred to an Excelera (Philips 
external workstation) for further processing. The data 
were analysed off-line by two independent investigators 
using the following parameters: longitudinal strain and 
strain rate.
From the colour-coded images of tissue Doppler, each 
observer measured strain and strain rate using a specific 
region of interest (ROI), with the same size of ROI in every 
measurement, that was manually positioned along the 
basal inferoseptal and basal anterolateral segments. 
The 17-segment model of LV was used in our study. The 
analysis of deformation included maximum strain values, 
that were read out in the time interval between aortic 
valve opening (AVO) and aortic valve closure (AVC). Each 
time during echocardiography AVO and AVC values were 
measured and reported in milliseconds (ms), than these 
data were entered into the Excelera system. 
Cardiopulmonary exercise testing
CPET was performed using symptoms limited treadmill 
exercise test with RAMP protocol. The electrocardiogram 
was continuously monitored for the heart rate, occurrence 
of ST segment changes or arrhythmias. Of the numerous 
parameters, peak oxygen uptake (peak VO2), peak carbon 
dioxide exertion (peak VCO2) and percent (%) of predicted 
and the slope of the VE/VCO2 relationship from the initia-
tion to peak exercise (VE/VCO2 slope) were used for the 
analysis [12].
The study is complied with the Declaration of Helsinki 
and was approved by the institutional medical ethics 
committee. Informed consent was obtained from all the 
individual participants included in the study. 
Statistical analysis
The distribution of all variables was verified with Kolmogo-
rov-Smirnov test. Data are expressed as mean ± standard 
deviation (SD) or median values with interquartile range 
(IQR) as appropriate. Statistical analysis was perfor-
med using Student’s t-test or Mann–Whitney U test for 
continuous data depending on distribution. Adequately 
Pearson’s or Spearman’s correlation coefficient were used 
of resynchronization therapy. Patients with moderate to 
severe chronic lung disease were excluded from the study. 
Venous blood samples were analysed for B-type na-
triuretic peptide (BNP), C-reactive protein (CRP), blood 
count, lipid profile, uric acid and creatinine concentrations 
in the local laboratory. The positive response to CRT was 
defined according to previous studies, by the improvement 
in clinical CHF symptoms (lower NYHA class, longer 6MWT 
distance) and at least a 15% relative reduction in LVESV 
in echocardiography, indicating reverse remodelling [10]. 
Echocardiography
Transthoracic echocardiography was performed with an ul-
trasound device (Philips iE33) with the use of transthoracic 
probe working with harmonic imaging within the frequency 
range of 1.6–3.2 MHz. Standard techniques were used to 
obtain M-mode, 2D and Doppler measurements in accor-
dance with the American Society of Echocardiography and 
the European Association of Cardiovascular Imaging guide-
lines [3]. Conventional echocardiographic LV end-diastolic 
dimensions (interventricular septum wall thickness, LV 
internal dimension and LV posterior wall thickness) were 
obtained from the parasternal long-axis view. LVEdV and 
LVEsV volumes and LVEF were measured manually using 
the biplane Simpson’s method in the 2D mode. We have 
adopted LVEF <50% as an abnormal LV systolic function. 
A decrease in LVend-systolic volume of ≥15% of the base-
line value, as measured by echocardiography six months 
after the device implantation, was used to define a CRT 
responder.
Strain analysis
Echocardiographic quantification of regional myocardial 
function is currently based on DTI or STE techniques. Both 
techniques provide comparable data quality, although DTI 
is known to be angle-dependent and slightly more time-
-consuming analysis [3]. The most commonly used strain-
-based measure of LV global systolic function is global 
longitudinal strain (GLS) [11]. 
Table 1. The localization of left-ventricular electrode in patients, 
who benefited (the responders) and who did not benefit from 
cardiac resynchronization therapy (the responders and the non-
responders, respectively)
Responders (n 
= 22)
Nonresponders 
(n = 13)
Lateral vein, % (n) 48.6 (17) 14.3 (5)
Antero-lateral vein, % (n) 17.1 (6) 2.8 (1)
Postero-lateral vein, % (n) 2.8 (1) 2.8 (1)
Great vein, % (n) 0 5.7 (2)
Posterior vein, % (n) 0 5.7 (2)
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to examine the relationship between two continuous va-
riables. P < 0.05 was considered as statistically significant. 
A statistical software package Statistica 10.0 (StatSoft 
USA) was used for analysis.
Reproducibility analysis
Intra- and inter-observer variability of strain measurements 
were evaluated. To test intra-observer variability, the same 
primary operator analysed data sets twice at least two 
weeks apart. The operator was blinded to the result of the 
previous measurements during second evaluation. To test 
inter-observer variability, a second experienced observer 
was given data sets with no access to information regarding 
all prior measurements. Intra- and inter-observer variability 
was calculated as an absolute difference between two 
measurements over the mean of those measurements and 
presented as the mean percentage error. Intra-observer 
variability for strain parameters was estimated at 10%, 
and for inter-observer variability — 12.9%.
Ethical approval 
The study was approved by the institutional medical ethics 
committee and is complied with the Declaration of Helsinki 
(1964). Informed consent was obtained from all the indivi-
dual study participants.
Results
Baseline characteristics of the study group is presented 
in Table 2. 
Six months after CRT CHF patients had a significant 
improvement in NYHA functional class, longer 6-MWT 
distance and decreased VE/VCO2 slope ratio (Table 2). 
According to functional parameters, the nonresponders 
had worse results comparing to the responders — shorter 
6MWT distance, lower peak VO2 and peak VCO2 and 
higher VE/VCO2 slope (Table 3). BNP concentration was 
significantly lower in the responders six months after CRT 
(Table 3). 
Table 2. Characteristics of CHF patients treated with CRT at baseline and six month follow-up.
CRT group 
Baseline
CRT group 
 6M follow-up
P value
Patients, No. 35 35
Age (years) 66.2 ± 9.5 66.9 ± 10.6 
Female sex, % (n) 11.5 (4) 11.5 (4)
BMI (kg/m2) 28.4 ± 4 28.9 ± 4.8 0.2
QRS duration (ms) 162.8 ± 33.8 145.2 ± 33.7 0.01
Functional parameters
NYHA functional class, % (n) 2.8 ± 0.4 2.4 ± 0.45 < 0.001
6MWD (m) 380 (240–435) 420 (350–480) < 0.001
Peak VO2 (ml/kg/min) 13.7 (11.8–17.6) 15.2 (11.6–20.2) 0.8
Peak VCO2 (l/min) 1.2 (0.8–1.44) 1.32 (0.7–1.85) 0.7
VE/VCO2 slope 32.5 (27.5–37.7) 29.9 (25.3–35.6) 0.02
Echocardiography
EF bi-p (%) 22 (20–25) 33 (25–37) < 0.001
LVDD (mm) 6.6 (6.2–7.2) 6.5 (5.8–7.2) 0.1
LVEDV (ml) 209 (175–284) 180 (129–213) 0.06
LVESV (ml) 166 (132–225) 126 (90–152) 0.02
Septal strain (%) -7.8 (-5.3– -11.5) -12.1 (-8.7– -14) < 0.001
Septal strain rate (1/s) 1.2 (0.7–1.2) 1.47 (0.95–1.75) 0.006
Lateral strain (%) -9.4 (-5.5– -14.8) -12.7 (-7.9– -17.2) 0.006
Lateral strain rate (1/s) 1.1 (0.87–1.6) 1.25 (1–1.95) 0.05
Laboratory analyses
BNP (pg/ml) 220 (90–705) 145 (59–374) 0.24
CRP (mg/dl) 2.15 (0.95–4) 1.6 (1–3.6) 0.21
Abbreviations: 6M follow-up — heart failure patients after six months of cardiac resynchronization therapy; 6MWD — six-minute walk test distance; BMI — body mass index; BNP — brain natriuretic peptide; 
CRP — C-reactive protein; EF bi-p — ejection fraction estimated with bi-plane method; LVDD — left ventricle diastolic diameter; LVEDV — left ventricle end-diastolic volume; LVESV — left ventricle end-systolic 
volume; Peak VCO2 — peak carbon dioxide excretion; Peak VO2 — peak oxygen uptake; VE/VCO2 slope, minute ventilation — carbon dioxide production relationship from the initiation to peak exercise. Data 
are presented as mean ± standard deviation, median and interquartile range (IQR) or number and percentage.
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Table 3. Characteristics of CHF patients at baseline and six month follow-up qualified as the responders or the nonresponders depending 
on the response to resynchronization therapy.
Nonresponders 
baseline
Nonresponders 
6M follow-up
P value Responders baseline Responders 6M 
follow-up
P value
Patients, No. 13 13 - 22 22 -
Age (years) 66.3 ± 9.8 66.7 ± 9.7 - 65.5 ± 9.6 65.9 ± 9.6 -
Female sex, % (n) 7.7 (1) 7.7 (1) - 13.6 (3) 13.6 (3) -
BMI (kg/m2) 28.2 ± 3 28.8 ± 4.8 0.8 28.5 ± 4.6 28.1 ± 3.8 0.8
QRS duration (ms) 172.3 ± 26.5 163.7 ± 31.5 0.3 163.3 ± 23.7 141 ± 21.4 0.02
Functional parameters
NYHA functional class, 
% (n)
2.9 ± 0.3 2.6 ± 0.4 0.03 2.8 ± 0.5 2.29 ± 0.44 < 0.001
6MWD (m) 240 (103–380) 300 (105–450) 0.01 390 (320–460) 420 (345–480) 0.005
Peak VO2 (ml/kg/min) 12 (10.8–12.2) 13.6 (8.2–16.1) 0.7 15.3 (12.1–17) 17.6 (12.1–0.5) 0.5
Peak VCO2 (l/min) 0.96 (0.87–1.1) 1.2 (0.6–1.4) 0.8 1.2 (0.8–1.5) 1.7 (0.8–2) 0.8
VE/VCO2 slope 42.3 (36.7–50.9) 34.9 (27.3–37.7) 0.2 31.3 (26.5–35.1) 29.1 (25.2–35) 0.2
Echocardiography
EF bi-p (%) 21 (20–22) 26 (20–33) 0.01 22 (20–26) 36 (32–39) < 0.001
LVDD (mm) 7.2 (6.2–7.6) 7 (6.5–7.4) 0.7 6.6 (6.2–6.6) 6.1 (5.7–6.6) < 0.001
LVEDV (ml) 284 (202–298) 250 (183–296) 0.3 195 (170–237) 145 (115–187) < 0.001
LVESV (ml) 211 (158–249) 167 (136–251) 0.1 156 (121–193) 96 (84–129) < 0.001
Septal strain (%) -9.1 (-7.5– -11.5) -12.1 (-8.8– -13) 0.04 -7.1 (-5.2– -11.1) -12.1 (-8.7– -14) 0.002
Septal strain rate (1/s) 1.25 (1–1.7) 1.5 (1.1–1.8) 0.6 0.9 (0.6–1.4) 1.4 (0.9–1.7) 0.003
Lateral strain (%) -9.4 (-5.5– -10.5) -12.1 (-6– - 17) 0.09 -10.4 (-6.1– -17.6) -13.8 (-8.9– -17.8) 0.03
Lateral strain rate (1/s) 1.05 (0.75–1.45) 1.1 (1–1.3) 0.3 1.2 (1–2) 1.3 (1–2) 0.1
Laboratory analyses
BNP (pg/ml) 727 (240–1409) 425 (190–548) 0.6 128 (85–297) 102 (36–166) 0.4
CRP (mg/dl) 2.4 (1–4.1) 1.8 (1.1–4.3) 0.3 1.9 (0.9–3.9) 1.4 (0.9–3.6) 0.3
Abbreviations: 6M follow-up — heart failure patients after six months of cardiac resynchronization therapy; 6MWD — six-minute walk test distance; BMI — body mass index; BNP — brain natriuretic peptide; 
CRP — C-reactive protein; EF bi-p — ejection fraction estimated with bi-plane method; LVDD — left ventricle diastolic diameter; LVEDV — left ventricle end-diastolic volume; LVESV — left ventricle end-systolic 
volume; Peak VCO2 — peak carbon dioxide excretion; Peak VO2 — peak oxygen uptake; VE/VCO2 slope, minute ventilation — carbon dioxide production relationship from the initiation to peak exercise. Data 
are presented as mean ± standard deviation, median and interquartile range (IQR) or number and percentage.
Twenty-two patients (62.8%) were the responders. 
There was no difference in CHF aetiology (dilated or is-
chaemic cardiomyopathy) between the responders and 
the nonresponders. There was no significant difference in 
baseline septal and lateral LPS measurements between 
the responders and the nonresponders. The baseline 
lateral LPS correlated with EF (r = 0.48, p = 0.01) i LVESV 
(r = –0.39, p = 0.035), while septal LPS correlated with 
intraventricular dyssynchrony (r = 0.38, p = 0.02).
In the responders group, 6-months after CRT implan-
tation, we observed significant improvement in septal and 
lateral LPS values (Table 3). However, the responders were 
characterised by higher increase in septal LPS six months 
after CRT comparing to the nonresponders (–4.6 ± 6.1 vs 
–2.4 ± 3.9% respectively, p = 0.045) (Figure 1A). It was 
reflected in the improvement in NYHA functional class 
(2.8 ± 0.4 vs 2.3 ± 0.4; p < 0.001). Changes in septal LPS 
correlated positively with baseline CPET parameters, such 
as peak oxygen uptake (VO2 peak) (r = 0.6, p = 0.004) 
(Figure 2a), peak carbon dioxide production (VCO2 peak) 
(r = 0.62, p = 0.002) (Figure 2B) and negatively with venti-
lation/carbon dioxide production relation (VE/VCO2slope) 
(r = -0.5, p = 0.037) (Figure 2C). 
The improvement in lateral LPS was observed in both 
groups without significant difference (–3.0 ± 6.0 vs –3.8 ± 
7.6%, p = 0.72) (Figure 1B). Also septal and lateral SR chan-
ges in the CRT course did not differ between those groups. 
Furthermore, six months after CRT, we observed sig-
nificant decrease in LVEdV and LVEsV in the responders 
(Table 3), while in the nonresponders group those para-
meters were higher at baseline and remained unchanged 
(Table 3).
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Discussion
Overall, the response rate to CRT is still not optimal and 
the cause of this phenomenon is multifactorial. Beyond 
the influence of CRT, the clinical response is also mediated 
by e.g. pharmacotherapy, comorbidities and inflammatory 
activation [13]. This is particularly evident in the case of 
patients, who, despite the lack of a positive response to CRT 
in echocardiographic assessment demonstrate improved 
functional parameters, such as the 6MWD or VO2 peak. 
This phenomenon was also observed in our study. 
An observational multicenter study (Predictors of 
Response to CRT) reported on the limited role of velocity 
dyssynchrony measurements by colour DTI in predicting 
the response to CRT. However, the study had several im-
portant limitations, including the enrollment of patients 
Figure 1. Changes of septal (Figure 1a) and lateral (Figure 1b) 
longitudinal peak strain (LPS) values in the nonresponders and 
the responders (six months follow-up measurement minus basic 
measurement).
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who did not meet criteria for CRT (20% of patients with 
EF>35%), overall low feasibility and reproducibility of DTI 
measurements, and using ultrasound systems and soft-
ware from different vendors, including systems that had 
lower temporal resolution than the time intervals to be 
measured [14]. Currently, for patients with QRS durations 
< 120 msec, the existing data do not support using DTI or 
M-mode measurements for the selection of patients for 
CRT [15]. On the other hand, a recent single-centre study 
showed, that radial dyssynchrony assessed by STE can be 
of value in predicting changes in LV volumes and EF after 
CRT in patients with QRS durations of 100 to 130 msec 
[16]. Another recent study showed, that the combination of 
timing and magnitude of longitudinal strain could predict 
the response to resynchronization [17].
In our study, the baseline septal and lateral LPS did 
not differ between the responders and the nonresponders. 
Bernard A. et al. [18] also showed, that the responders 
and the nonresponders had similar baseline values of re-
gional peak strain, while the other investigators observed 
significantly higher baseline values longitudinal strain in 
the CRT responders [19]. 
In our study we observed significant improvement in 
values of septal and lateral LPS, as well as decrease in 
LVEdV and LVEsV in the responders after six months of 
CRT. Furthermore, our analyses of septal and lateral strain 
curves showed significant improvements in septal strain 
during systole in the responders patients with LBBB, that is 
consistent with other analysis [20]. We showed only slight 
improvement of lateral wall contractility in both groups 
of patients. In another studies, at follow-up, significant 
improvements of midlateral LPS were noted only in the 
responders, whereas a decrease of LPS was observed in 
the nonresponders [18]. 
Kang Y et al. [21] observed, that longitudinal strain 
and LBBB combined with a wide QRS can help to predict 
positive response to CRT effectively and reliably. In another 
study, none of the longitudinal strain indices was different 
between echocardiographic responders and nonrespon-
ders to CRT [22]. Similarly, Maffè et al. [23] on univariate 
and multivariate analysis showed, that only interventricular 
mechanical delay (IVMD), not longitudinal strain, was sig-
nificantly associated with a complete echocardiographic 
response to CRT. In our study, the baseline septal and 
lateral LPS did not differ between the responders and the 
nonresponders and therefore this measurements are not 
relevant in predicting CRT-related improvement.
In our study, LPS values correlated well with EF, which 
is consistent with investigations of other authors [24]. 
This study showed, for the first time, the strong cor-
relation of strain measurements and CPET parameters 
reflecting cardiopulmonary functional capacity, such 
as peak oxygen consumption or VE/VCO2 slope. This is 
important finding, because it has been shown, that peak 
VO2, as well as VE/VCO2 slope are important markers of 
prognostic values [25]. In our study, the changes of septal 
LPS in the course of CRT correlated with CPET oxygen 
and carbon dioxide exchange parameters at baseline, 
while after six months those observations were signifi-
cant for measurements at anaerobic threshold. This fact 
highlights, that the most relevant information of patients 
clinical status is given by the anaerobic threshold level 
and the accompanying efficiency of the gas exchange. 
These correlations were not observed in classical echo-
cardiographic parameters, therefore septal LPS appears 
to be a better marker of clinical capacity improvement 
comparing to e.g. LVEF. 
Conclusions
LV regional LPS appears to be a good parameter in reflec-
ting the improvement of clinical status in patients treated 
with CRT. Patients, who benefited from CRT had better 
improvement of septal LPS, therefore positive response to 
this therapy may be related to the improvement of septal 
contractility.
Limitations
Combined assessment of baseline longitudinal strain and 
its acute reduction after CRT may have clinical implica-
tions for predicting the responders, and thus patients’ 
care. Although our findings are promising, literature data 
are divergent. A limitation of the study is the lack of echo-
cardiographic measurements directly after the device 
implantation. Further, our study was based on relatively 
small number of selected, optimally treated stable CHF 
patients, therefore this group may be not representative 
of whole CHF patients.
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Streszczenie
Wstęp. Odkształcenie miokardium i tempo tego odkształcania (strain i SR, strain rate) to metody w tkankowej echokar-
diografii doplerowskiej wnoszące informacje o regionalnej kurczliwości mieśnia. Celem badania była ocena przydatności 
pomiarów strain i SR w ocenie odpowiedzi na terapię resynchronizującą (CRT) u chorych z przewlekłą niewydolnością 
serca (CHF).
Materiał i metody. Do badania włączono 35 pacjentów z CHF i czasem trwania zespołów QRS ≥ 120 ms i morfologią 
LBBB. Parametry biochemiczne i kliniczne były oceniane przed implantacją i 6 miesięcy po wszczepieniu CRT. Analizie 
poddano wybrane parametry z badania echokardiograficznego przezklatkowego i metodą Dopplera tkankowego — od-
kształcenie podłużne miokardium na szczycie skurczu — (LPS, longitudinal peak systolic strain) i tempo odkształcania 
(SR, strain rate) mierzone dla segmentu przypodstawnego przegrody międzykomorowej i ściany bocznej lewej komory. 
Wyniki. Dwudziestu dwóch pacjentów (62,8%) odniosło korzyść z CRT i wykazało poprawę w zakresie wartości przegro-
dowego i bocznego LPS w obserwacji 6-miesięcznej [odpowiednio: -7,1 (-5,2– -11,1) vs – 12,1 (-8,7– -14)%, p = 0,002; 
-10,4 (-6,1– -17,6) vs –13,8 (-8,9– -17,8)%, p = 0,03]. Osoby odnoszące korzyść z CRT po 6 miesiącach wykazywały 
większy wzrost przegrodowego LPS w stosunku do nonresponderów (-4,6 ± 6,1 vs -2,4 ± 3,9%, p = 0 045). Zmiany LPS 
w obrębie przegrody pozytywnie korelowały z wyjściowymi parametrami uzyskanymi w badaniu ergospirometrycznym: 
szczytowym pochłanianiem tlenu (r = 0,6, p = 0,004), szczytowym wydalaniem dwutlenku węgla (r = 0 62, p = 0 002) 
oraz negatywnie z VE/VCO2 slope (r = -0,5, p = 0,037).
Wnioski. Regionalne odkształcenie podłużne wybranych segmentów lewej komory jest parametrem odzwierciedlającym 
poprawę stanu klinicznego pacjentów leczonych terapią resynchronizującą. Chorzy odnoszący korzyść z terapii resyn-
chronizującej wykazują lepszą poprawę przegrodowego LPS, w związku z czym pozytywna odpowiedź na terapię może 
mieć związek z poprawą kurczliwości w obrębie przegrody międzykomorowej.
Słowa kluczowe: odkształcenie miokardium, echokardiografia, terapia resynchronizująca serca, przewlekła niewydolność  
serca, blok lewej odnogi pęczka Hisa
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